Production (Stage)
Elanco Animal Health Incorporated
ELAN
$13.81
-$0.36-2.54%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 109.38% | 94.33% | 133.21% | 48.45% | -68.93% |
| Total Depreciation and Amortization | -3.01% | 5.98% | -1.73% | -8.47% | -4.05% |
| Total Amortization of Deferred Charges | -- | -25.93% | -- | -- | -- |
| Total Other Non-Cash Items | 126.32% | -84.21% | -156.67% | 340.00% | -205.56% |
| Change in Net Operating Assets | -33.90% | -61.64% | 818.52% | 164.71% | 59.68% |
| Cash from Operations | -300.00% | 12.74% | -18.18% | 227.87% | 101.38% |
| Capital Expenditure | -170.83% | -14.63% | -27.27% | 19.05% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -86.36% | -- | -- | -- | -- |
| Other Investing Activities | 60.00% | -216.67% | -- | 200.00% | 66.67% |
| Cash from Investing | -256.76% | -157.14% | 3,555.56% | 23.26% | 167.27% |
| Total Debt Issued | 150.00% | -- | 0.00% | 140.00% | -50.00% |
| Total Debt Repaid | -57.52% | 72.66% | -232.41% | -1,530.77% | -494.74% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -42.86% | -- | -700.00% | -150.00% | -100.00% |
| Cash from Financing | 292.59% | 76.98% | -753.50% | -338.46% | -115.52% |
| Foreign Exchange rate Adjustments | 252.63% | -- | 366.67% | 62.50% | -1,800.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 371.43% | -29.41% | 3,600.00% | 44.90% | 74.07% |